Skip to main content
. 2009 Mar;16(2):36–43. doi: 10.3747/co.v16i2.428

FIGURE 1.

FIGURE 1

Example of inhibitors that, in early clinical trials, are targeting cyclin-dependent kinases (cdks) acting in or outside of the cell cycle.